Full Text View
Tabular View
No Study Results Posted
Related Studies
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) (vivitrol)
This study has been completed.
Study NCT00453609   Information provided by State University of New York - Upstate Medical University

First Received on March 27, 2007.   Last Updated on December 10, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Bipolar Disorder
Alcohol Dependence
Additional conditions recognized in this trial
Alcoholism
Mental Disorders
Psychotic Disorders
More general conditions related to this trial
Affective Disorders, Psychotic
Alcohol-Related Disorders
Mood Disorders
Schizophrenia and Disorders with Psychotic Features
Substance-Related Disorders
Interventions listed in this trial
long-lasting injectable naltrexone
Additional drug interventions recognized in this trial
Naltrexone
More general drug interventions related to this trial
Central Nervous System Agents
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
State University of New York - Upstate Medical University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services